OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder

Sievert, K-D., Chapple, C. orcid.org/0000-0002-2960-9931, Herschorn, S. et al. (4 more authors) (2014) OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder. International Journal of Clinical Practice, 68 (10). pp. 1246-1256. ISSN 1368-5031

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2014 The Authors. International Journal of Clinical Practice published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Dates:
  • Published: October 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 02 May 2017 08:53
Last Modified: 02 May 2017 08:53
Published Version: http://doi.org/10.1111/ijcp.12443
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1111/ijcp.12443
Related URLs:

Share / Export

Statistics